Skip to main content
Contact Us
Subscribe
E-Edition
42°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Point Biopharma Global Inc
(NQ:
PNT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
12.49 (70)
Ask (Size)
12.51 (49)
Prev. Close
12.50
Today's Range
N/A - N/A
52wk Range
12.43 - 14.35
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned
December 27, 2023
With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole...
Via
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c
Via
Benzinga
Performance
More News
Read More
Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?
December 18, 2023
Via
Benzinga
Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment
November 29, 2023
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Recap: POINT Biopharma Global Q3 Earnings
November 13, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In November
November 17, 2023
Via
Benzinga
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via
PressReach
POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT
October 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review
October 06, 2023
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Why Point BioPharma Global Stock Skyrocketed 86% This Week
October 05, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2023
October 04, 2023
Via
Benzinga
Why Eli Lilly Stock Was Looking Sickly Today
October 03, 2023
Via
The Motley Fool
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Shares of Point Biopharma Global Are Soaring Tuesday
October 03, 2023
Via
The Motley Fool
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 03, 2023
Via
Benzinga
Nasdaq Down Over 200 Points; US Job Openings Rise In August
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Point Biopharma Stock Nearly Doubles On Eli Lilly Deal
October 03, 2023
Via
Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS)
October 03, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Via
Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Falls Over 100 Points; McCormick Sales Miss Views
October 03, 2023
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
